| 000 | 01540 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250511201823.0 | ||
| 264 | 0 | _c19911017 | |
| 008 | 199110s 0 0 eng d | ||
| 022 | _a0022-3565 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAli, H | |
| 245 | 0 | 0 |
_aMethylxanthines block antigen-induced responses in RBL-2H3 cells independently of adenosine receptors or cyclic AMP: evidence for inhibition of antigen binding to IgE. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _cSep 1991 |
||
| 300 |
_a954-62 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_a1-Methyl-3-isobutylxanthine _xpharmacology |
| 650 | 0 | 4 |
_aAdenosine _xanalogs & derivatives |
| 650 | 0 | 4 | _aAdenosine-5'-(N-ethylcarboxamide) |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntigens _ximmunology |
| 650 | 0 | 4 |
_aCyclic AMP _xphysiology |
| 650 | 0 | 4 |
_aDinitrophenols _ximmunology |
| 650 | 0 | 4 |
_aImmunoglobulin E _ximmunology |
| 650 | 0 | 4 | _aPurinergic Antagonists |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aReceptors, Purinergic _xclassification |
| 650 | 0 | 4 |
_aSerum Albumin, Bovine _ximmunology |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 650 | 0 | 4 |
_aType C Phospholipases _xmetabolism |
| 650 | 0 | 4 |
_aVasodilator Agents _xpharmacology |
| 650 | 0 | 4 |
_aXanthines _xpharmacology |
| 700 | 1 | _aMüller, C E | |
| 700 | 1 | _aDaly, J W | |
| 700 | 1 | _aBeaven, M A | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 258 _gno. 3 _gp. 954-62 |
|
| 999 |
_c1722713 _d1722713 |
||